Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Malcikova

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Immunology|October 9, 2007
Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemiaJ Malcikova, J Smardova, S Pekova, et al.
Leukemia|February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemiaS Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia|October 8, 2014
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemiaJ Malcikova, K Stano-Kozubik, B Tichy, et al.
Leukemia|July 27, 2017
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational statusB Kubesova, S Pavlova, J Malcikova, et al.
Leukemia|February 23, 2018
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretationJ Malcikova, E Tausch, D Rossi, et al.
Leukemia|November 6, 2014
The impact of SF3B1 mutations in CLL on the DNA-damage responseG D Te Raa, I A M Derks, V Navrkalova, et al.
Leukemia|September 24, 2010
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutationsT Zenz, D Vollmer, M Trbusek, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Immunology|October 9, 2007
Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemiaJ Malcikova, J Smardova, S Pekova, et al.
Leukemia|February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemiaS Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia|October 8, 2014
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemiaJ Malcikova, K Stano-Kozubik, B Tichy, et al.
Leukemia|July 27, 2017
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational statusB Kubesova, S Pavlova, J Malcikova, et al.
Leukemia|February 23, 2018
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretationJ Malcikova, E Tausch, D Rossi, et al.
Leukemia|November 6, 2014
The impact of SF3B1 mutations in CLL on the DNA-damage responseG D Te Raa, I A M Derks, V Navrkalova, et al.
Leukemia|September 24, 2010
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutationsT Zenz, D Vollmer, M Trbusek, et al.
Pageof 1